Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1995
Business Overview: Chemed operates through four primary segments: National Sanitary Supply (wholesale distribution), Roto-Rooter (plumbing and drain cleaning), Tidi Products (medical and dental supplies), and Patient Care (home health services).
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1995 | Nine Months Ended Sep 30, 1995 | YoY Change (9 Months) |
|---|---|---|---|
| Total Sales & Service Revenues | $177,554,000 | $524,756,000 | +9.4% |
| Income from Operations | $8,681,000 | $23,228,000 | +24.9% |
| Net Income | $7,550,000 | $19,141,000 | +1.9% |
| Diluted EPS (Net Income) | $0.77 | $1.94 | +1.6% |
| Operating Cash Flow (9 Months) | N/A | $14,530,000 | -14.1% |
| Cash & Cash Equivalents | $9,270,000 | $9,270,000 | +96.3% (vs. Dec 31, 1994) |
| Total Debt (Current + Long-term) | $119,909,000 | $119,909,000 | -2.3% (vs. Dec 31, 1994) |
| Operating Margin (9 Months) | 4.8% | 4.4% | +0.3 pts |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 9.4% year-over-year for the nine-month period. The Patient Care segment drove significant growth with a 32% revenue increase, followed by National Sanitary Supply (+11%) and Roto-Rooter (+5%). Tidi Products revenues declined 4% due to the divestiture of its retail division.
- Profitability: Income from continuing operations rose 50.8% year-over-year for the nine-month period ($16.4M vs. $10.9M). This was driven by higher operating profits in National Sanitary Supply and Patient Care, and reduced nonrecurring expenses compared to 1994.
- Nonrecurring Items: The 1995 period included $538,000 in nonrecurring expenses related to a withdrawn proposal to acquire a minority interest in Roto-Rooter. This compares to $1.7M in nonrecurring expenses in the prior year related to downsizing and marketing refocusing.
- Investment Gains: Other income increased significantly due to larger gains on the sale of investments ($9.1M gain in 9 months 1995 vs. $5.3M in 1994).
- Divestitures and Acquisitions: The company sold its Veratex Retail division for $10M cash plus a note, and acquired the CSD Medical Division for $7.65M cash.
Guidance, Outlook, and Risks
- Liquidity: Management states that sources of capital and liquidity are satisfactory. The company holds approximately $38.1M in unused lines of credit.
- Strategic Focus: The sale of the Veratex Retail division allows the Tidi Products Group to focus on wholesale manufacturing and distribution. A supply agreement with the buyer (Henry Schein Inc.) ensures annual minimum purchases for ten years.
- Tax Rate: The effective income tax rate increased to 38.1% for the nine-month period (from 37.1% in 1994) due to lower favorable tax adjustments and ESOP dividend tax credits.
- Risks/Contingencies: The filing notes a contingent payment of up to $2M from the Veratex Retail sale, dependent on combined sales performance in 1996. The company also noted that the withdrawn Roto-Rooter acquisition proposal resulted in evaluation costs.
Investor Verification Checklist
- Investment Gains: Verify the sustainability of earnings given the significant contribution of investment gains ($5.9M after-tax for 9 months) to net income.
- Segment Margins: Confirm the trend in Roto-Rooter's operating margin, which declined to 8.5% (9 months) due to nonrecurring costs and service contract volume issues.
- Divestiture Impact: Assess the long-term impact of the Veratex Retail sale on Tidi Products' revenue base, despite the reported margin improvement.
- Debt Structure: Review the composition of the $120M total debt, specifically the $25M in bank notes and loans payable.
- Discontinued Operations: Note that net income includes adjustments related to discontinued operations ($2.7M for 9 months 1995), which should be excluded when analyzing core operational performance.